Biological Industries

Cromwell, United States Founded: 1982 • Age: 44 yrs Acquired By Sartorius
Cell culture media development and manufacturing services

About Biological Industries

Biological Industries is a Healthcare company based in Cromwell (United States) founded in 1982, and was acquired by Sartorius in December 2019. Cell culture media development and manufacturing services. Biological Industries has raised $11 million across 1 funding round from investors including Sartorius and Fortissimo Capital. The company has 5 employees. Biological Industries offers products and services including Octet® R2, Ambr® 15 Cell Culture, Cell Culture Media, Flexsafe® Pro Mixer, and iQue® Platform. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is BIOLOGICAL INDUSTRIES USA INC. Its competitors include BioLife Solutions, RoosterBio and OriGene; 2 of its 3 listed competitors have raised funding.

Company details

Biological Industries was founded in 1982 and is based in Cromwell, United States. Services are offered to the life science sector, with emphasis on cell culture media development and manufacturing. The portfolio includes classical media, supplements, and reagents for stem cell research and cell therapy, as well as serum-free options for animal cell culture and molecular biology. A U.S. division was established in Connecticut in 2015 to support operations.

  • Headquarters Cromwell, United States
  • Employees 5
  • Stage Acquired
  • Sectors
    Healthcare
  • Website bioind.com
  • Social LinkedIn Facebook
  • Acquired by Sartorius (Dec 2019)
  • Legal Name Biological Industries Usa Inc
Key Metrics
  • Total Equity Funding
    $11M (USD)

    in 1 rounds

  • Latest Funding Round
    $11M (USD), Private Equity Round

    Apr 2017

  • Investors
    Sartorius

    & 1 more

  • Employee Count
    5
  • Acquired by
    Sartorius

    (Dec 2019)

Products & Services of Biological Industries

Biological Industries offers a comprehensive portfolio of products and services, including Octet® R2, Ambr® 15 Cell Culture, Cell Culture Media, Flexsafe® Pro Mixer, and iQue® Platform.

Octet® R2
BLI Instrument

Device for biolayer interferometry to analyze molecular interactions

Ambr® 15 Cell Culture
Bioreactor

Multi-parallel system for high-throughput cell culture processes

Cell Culture Media
Reagents

Specialty media for HEK293 and CHO cells in biopharmaceutical applications

Flexsafe® Pro Mixer
Mixing Equipment

Single-use mixer for liquid handling in bioprocessing

iQue® Platform
High-Throughput Screening

System for cytometry-based cell analysis in research

Funding Insights of Biological Industries

Biological Industries has successfully raised a total of $11M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $11 million completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $11M
  • Total Rounds 1
  • Last Round Private Equity Round — $11M
  • First Round $11M

    (Apr 2017)

  • Investors Count 1

All 1 funding rounds of Biological Industries with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2017$11MPrivate Equity Round––
Valuation history

2 investors in total: 2 institutional.

Investors in Biological Industries

Biological Industries has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Sartorius and Fortissimo Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
ffcapital.com
Laboratory and biopharmaceutical equipment is developed for production processes.
1870sartorius.comGottingen, Germany
Premium access

Investor details for Biological Industries

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Biological Industries

3 dated milestones of Biological Industries across 37 years, from founding to its latest funding, stage changes and deals.

  1. Founded Biological Industries is founded.
  2. Funding First funding round of $11.0M.
  3. Exit Acquired by Sartorius.

Competitors of Biological Industries

Biological Industries has 3 listed competitors in our database, 2 of them funded. They include BioLife Solutions, RoosterBio and OriGene.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
biolifesolutions.com1987Bothell, United States685
Tissue hypothermic storage and cryopreservation freeze media are developed.
roosterbio.com2012Frederick, United States$38.41M69
Developer of human mesenchymal stem cells and extracellular vesicles
origene.com1996Rockville, United States$69.55M141
Proteins, antibodies, and molecular tools are manufactured for research applications.
Premium access

Detailed competitors of Biological Industries

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Biological Industries

Websites that share an audience with Biological Industries (bioind.com).

Similar websites

Websites whose visitors overlap most with Biological Industries. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
bio-rad.com
100%
665.2K#79,666View details
biolegend.com
87%
229.6K#142,656View details
allelebiotech.com
74%
3.3K#5,141,194View details
encorbio.com
71%
#3,038,138View details
biochrom.de
biochrom.de
68%
–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 21 similar websites and full traffic analytics for Biological Industries

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 21 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as Biological Industries (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Biological Industries

Premium access

Complete news archive for Biological Industries

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biological Industries

Biological Industries was founded in 1982 and raised its 1st funding round 35 years after it was founded.

Biological Industries is headquartered in Cromwell, United States. It is registered at Cromwell, Connecticut, United States.

Biological Industries is a funded company, having raised a total of $11M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $11M, raised on Apr 2017.

Biological Industries has 5 employees.

Biological Industries was founded in 1982 and is based in Cromwell, United States. Services are offered to the life science sector, with emphasis on cell culture media development and manufacturing. The portfolio includes classical media, supplements, and reagents for stem cell research and cell therapy, as well as serum-free options for animal cell culture and molecular biology. A U.S. division was established in Connecticut in 2015 to support operations.

Biological Industries's top competitors include RoosterBio, BioLife Solutions and OriGene.

Biological Industries offers Octet® R2, Ambr® 15 Cell Culture, Cell Culture Media, Flexsafe® Pro Mixer, and iQue® Platform.

Biological Industries has 2 investors. Key investors include Sartorius, and Fortissimo Capital.

Biological Industries operates through Biological Industries Usa Inc.

Yes. Biological Industries was acquired by Sartorius in December 2019.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available